EUVIMEDEUVIMED entdecken
Crossref

Streptospherin A, a New Cancer Stem Cell Inhibitor, Produced by Streptomyces sp. KUSC-240

Hiroaki Ikeda, Ami Mimura, Saki Makita, Kayo Funayama, Morihiro Shibasaki, Taiki Suo, Saya Yoshida, Takefumi Kuranaga, Kazutoshi Shindo, Kazuo Furihata, Masaya Imoto, Hideaki Kakeya

Chemical and Pharmaceutical Bulletin · 2025

DOI: 10.1248/cpb.c25-00097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Hiroaki Ikeda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto …. Hauptthemen laut MEDLINE: Streptomyces, Neoplastic Stem Cells, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) are a major cause of tumor recurrence; therefore, using CSC inhibitors is a potential strategy for cancer chemotherapy. We used our previously reported screening system that targets CSCs to identify a new scarce compound, streptospherin A (1), isolated from Streptomyces sp. KUSC-240. The planar structure of 1 was determined by high-resolution-MS (HR-MS) and NMR analysis. Nuclear Overhauser effect spectroscopy correlation and J-resolved heteronuclear multiple bond connectivity analysis revealed the partial relative configuration on the tetrahydropyran ring. Streptospherin A (1) inhibited CSC sphere formation and suppressed the growth of CSCs. These results suggest that streptospherin A (1) is a potential anticancer agent that may target CSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptomycesNeoplastic Stem CellsAntineoplastic AgentsHumansCell ProliferationDrug Screening Assays, AntitumorMolecular StructureCell Line, TumorStructure-Activity RelationshipDose-Response Relationship, Drug

Stichwörter der Autor:innen

Streptomyces sp.anticancercancer stem cellnatural productstructural determination

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-machi, Sakyo-ku, Kyoto 606-8501,…
  • Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan.
  • Department of Food and Nutrition, Japan Women's University, 2-8-1 Mejirodai, Bunkyo-ku, Tokyo 112-8681, Japan.
  • Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
  • Department of Neurology, Division of Development of Autophagy Modulating Drugs, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Zitieren

APA

Ikeda, H., Mimura, A., Makita, S., Funayama, K., Shibasaki, M., Suo, T., Yoshida, S., Kuranaga, T., Shindo, K., Furihata, K., Imoto, M., & Kakeya, H. (2025). Streptospherin A, a New Cancer Stem Cell Inhibitor, Produced by Streptomyces sp. KUSC-240. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00097

Vancouver

Ikeda H, Mimura A, Makita S, Funayama K, Shibasaki M, Suo T, et al. Streptospherin A, a New Cancer Stem Cell Inhibitor, Produced by Streptomyces sp. KUSC-240. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00097

BibTeX
@article{Ikeda2025,
  author = {Ikeda, Hiroaki and Mimura, Ami and Makita, Saki and Funayama, Kayo and Shibasaki, Morihiro and Suo, Taiki and Yoshida, Saya and Kuranaga, Takefumi and Shindo, Kazutoshi and Furihata, Kazuo and Imoto, Masaya and Kakeya, Hideaki},
  title = {Streptospherin A, a New Cancer Stem Cell Inhibitor, Produced by Streptomyces sp. KUSC-240},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2025},
  doi = {10.1248/cpb.c25-00097}
}
Kostenlos starten →